SCHEMBL1486473

SCHEMBL1486473

CC1(C)OC(=O)C(CNc2cccc(OCc3ccccc3)c2)C(=O)O1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.46
FAAH O00519 1/20 0.45
MGLL Q99685 1/20 0.45
STK10 O94804 1/20 0.44
SLK Q9H2G2 1/20 0.44
CTSV O60911 1/20 0.44
CTSL P07711 1/20 0.44
PDK1 Q15118 1/20 0.43
PDK2 Q15119 1/20 0.43
PDK3 Q15120 1/20 0.43
PDK4 Q16654 1/20 0.43
MAOB P27338 3/20 0.43
BCHE P06276 2/20 0.43
SIRT1 Q96EB6 1/20 0.43
LIPC P11150 1/20 0.43
ACHE P22303 1/20 0.43
LIPE Q05469 1/20 0.43
SIRT2 Q8IXJ6 1/20 0.42
LMNA P02545 1/20 0.42
MEN1 O00255 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1486613 0.87 NPC1 (0.47) MEN1KMT2AALDH1A1GAAMAPT
SCHEMBL3097423 0.82 GLA (0.52) FFAR1FAAHMGLLMAOBBCHE
SCHEMBL1486434 0.79 FFAR1 (0.47) FFAR1FAAHMGLLCTSVCTSL
SCHEMBL12003807 0.77 ALDH1A1 (0.67) STK10SLKCTSVCTSLPDK1
SCHEMBL3103917 0.74 GLA (0.66) FFAR1FAAHMGLLMAOBBCHE
SCHEMBL17780993 0.74 MAOB (0.42) FAAHMGLLMAOBMEN1KMT2A
SCHEMBL311212 0.74 MAOB (0.42) FAAHMGLLMAOBMEN1KMT2A
SCHEMBL8167077 0.73 MAOB (0.58) FFAR1CTSVCTSLPDK1PDK2
SCHEMBL2496071 0.72 MAOB (0.42) FAAHMGLLMAOBBCHELIPC
SCHEMBL5310163 0.72 MEN1 (0.68) FFAR1MAOBBCHELMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7897597-B2 Aryloxy and arylalkyleneoxy substituted imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-03-01 US disclosed
US-20090018122-A1 Aryloxy and Arylalkyleneoxy Substituted Imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018122-A1 Aryloxy and Arylalkyleneoxy Substituted Imidazoquinolines IL2, IFNG, IRF3 FFAR1 1740/4885FAAH 2520/4885MGLL 3499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.